FIORENTINI, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 7.737
AS - Asia 3.550
EU - Europa 3.121
SA - Sud America 526
AF - Africa 81
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 7
Totale 15.045
Nazione #
US - Stati Uniti d'America 7.614
CN - Cina 1.319
SG - Singapore 1.230
UA - Ucraina 712
IT - Italia 560
DE - Germania 501
BR - Brasile 449
HK - Hong Kong 367
FI - Finlandia 260
FR - Francia 228
GB - Regno Unito 222
VN - Vietnam 160
RU - Federazione Russa 157
TR - Turchia 140
PL - Polonia 135
IN - India 134
IE - Irlanda 121
CA - Canada 74
SE - Svezia 69
BD - Bangladesh 45
AR - Argentina 38
MX - Messico 30
ZA - Sudafrica 27
ES - Italia 25
JP - Giappone 24
NL - Olanda 24
CZ - Repubblica Ceca 23
AU - Australia 22
BE - Belgio 22
IQ - Iraq 22
AT - Austria 14
ID - Indonesia 14
CO - Colombia 12
NG - Nigeria 12
PK - Pakistan 11
UZ - Uzbekistan 11
IR - Iran 10
LT - Lituania 9
MA - Marocco 9
AZ - Azerbaigian 8
EG - Egitto 7
EU - Europa 7
JO - Giordania 7
VE - Venezuela 7
CH - Svizzera 6
KE - Kenya 6
PT - Portogallo 6
EC - Ecuador 5
IL - Israele 5
KR - Corea 5
KZ - Kazakistan 5
LB - Libano 5
PY - Paraguay 5
SA - Arabia Saudita 5
CR - Costa Rica 4
ET - Etiopia 4
JM - Giamaica 4
NO - Norvegia 4
RO - Romania 4
BG - Bulgaria 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
MU - Mauritius 3
PH - Filippine 3
SN - Senegal 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
BO - Bolivia 2
HR - Croazia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
MY - Malesia 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
CG - Congo 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
EE - Estonia 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
IM - Isola di Man 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
Totale 15.035
Città #
Fairfield 752
Woodbridge 676
Ashburn 663
Singapore 658
Houston 521
Jacksonville 501
San Jose 402
Hong Kong 361
Ann Arbor 346
Cambridge 325
Seattle 311
Chandler 301
Wilmington 294
Beijing 267
The Dalles 224
Princeton 215
Dallas 177
Nanjing 174
Helsinki 142
Brescia 139
New York 136
Warsaw 133
Los Angeles 121
Dublin 120
Lauterbourg 100
Istanbul 99
Dearborn 85
Nanchang 74
Munich 72
Des Moines 69
San Francisco 54
Shanghai 51
Tianjin 49
Hebei 48
Shenyang 46
Buffalo 45
Chicago 45
Milan 44
Ho Chi Minh City 43
Changsha 40
Moscow 40
São Paulo 40
Orem 39
San Diego 39
Redondo Beach 38
Jinan 37
Hanoi 34
Kunming 32
Boardman 31
Jiaxing 29
London 29
Brooklyn 27
Council Bluffs 26
Toronto 26
Santa Clara 25
Rome 24
Tokyo 24
San Mateo 23
Guangzhou 22
Verona 22
Brussels 21
Hangzhou 21
Lancaster 21
Montreal 21
Turku 20
Kocaeli 19
Zhengzhou 19
Ningbo 18
Chennai 17
Johannesburg 17
Brno 16
Boston 15
Leawood 15
Stockholm 14
Taizhou 14
Haikou 13
Amsterdam 12
Atlanta 12
Augusta 12
Lanzhou 12
Mexico City 12
Nuremberg 12
Baghdad 11
Denver 11
Manchester 11
Mumbai 11
Paris 11
Poplar 11
Porto Alegre 11
Pune 11
Rio de Janeiro 11
Abuja 10
Frankfurt am Main 10
Ottawa 10
Phoenix 10
Ankara 9
Ardabil 9
Charlotte 9
Haiphong 9
Baku 8
Totale 10.066
Nome #
L’espressione della molecola CD11b identifica linfociti T CD8+CD28+ con fenotipo e funzioni sia di cellule naive/di memoria che effettrici. 261
Adult human heart microvascular endothelial cells are permissive for non-lytic infection by human cytomegalovirus. 243
U94 of human herpesvirus 6 inhibits in vitro angiogenesis and lymphangiogenesis. 224
Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study. 216
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 213
A partially humanized monoclonal antibody to human IFN-gamma inhibits cytokine effects both in vitro and in vivo. 206
Role of HIV-1 matrix protein p17 variants in lymphoma pathogenesis. 206
A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation 204
A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting. 201
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 201
A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17 196
HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor. 188
Betaherpesvirus Reactivation and Toll-Like Receptor Expression After Allogeneic Stem Cell Transplantation. 188
Human cytomegalovirus productively infects lymphatic endothelial cells and induces a secretome that promotes angiogenesis and lymphangiogenesis through interleukin-6 and granulocyte-macrophage colony-stimulating factor. 183
EXPRESSION OF TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: ONGOING RESULTS OF A PROSPECTIVE STUDY. 182
Detection of HIV-1 matrix protein p17 quasispecies variants in plasma of chronic HIV-1-infected patients by ultra-deep pyrosequencing. 180
Anti-Inflammatory Effect of 3,4-DHPEA-EDA [2-(3,4 -Hydroxyphenyl) ethyl (3S, 4E)- 4-Formyl-3-(2-Oxoethyl)Hex-4-Enoate] on Primary Human Vascular Endothelial Cells. 179
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 177
The immunomodulatory molecule pidotimod induces the expression of the nod-like receptor nlrp12 and attenuates tlr-induced inflammation. 176
Profile of Toll-Like Receptors on Peripheral Blood Cells in Relation to Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation 175
CD11b expression identifies CD8(+)CD28(+) T lymphocytes with phenotype and function of both naive/memory and effector cells 173
Acute graft-versus-host disease and expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation 171
Expression of Toll-Like Receptors on Peripheral Blood Cells After Allogeneic Stem Cell Transplantation: Results of a Prospective Study. 167
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 165
Espansione di una rara popolazione linfocitaria con fenotipo CD8+CD28-CD11b- in pazienti sieropositivi per HIV. 164
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. 163
Human herpesvirus-6 modulates RANTES production in primary human endothelial cell cultures. 159
The U94 Gene of Human Herpesvirus 6: A Narrative Review of Its Role and Potential Functions 158
Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope. 157
For timing of HAART is less more? CD4+/CD8+ ratio and CD4+ percentage as surrogate markers for more complex immunological features. 156
Synthetic peptide AT20 coupled to KLH elicits antibodies against a conserved conformational epitope from a major functional area of the HIV-1 matrix protein p17. 156
Correction to: Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh. 154
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 153
Syndecan-1 increases B-lymphoid cell extravasation in response to HIV-1 Tat via αvβ3/pp60src/pp125FAK pathway 151
Emergence of carbapenem-resistant Klebsiella Pneumoniae strains producing KPC-3 in Brescia Hospital, Italy. 146
Restriction of T-cell repertoires in idiophatic CD4+ lymphocytopenia. 145
HIV p17 enhances lymphocyte proliferation and HIV-1 replication after binding to a human serum factor. 144
Detection of KI WU and Merkel cell polyomavirus in respiratory tract of cystic fibrosis patients. 144
HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis. 144
A monoclonal antibody to the NH2-terminal region of HuIFN inhibits the antiproliferative activity of the lymphokine without affecting its internalization 143
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 142
V-region and Class Specific RT-PCR Amplification of Human Immunoglobulin Heavy and Light Chain Genes from B-Cell Lines. 140
HIV-1 matrix protein p17 and its receptors. 140
Human metapneumovirus-associated hospital admissions over five consecutive epidemic seasons: Evidence for alternating circulation of different genotypes 138
The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant. 136
CD8 lymphocytosis is sustained primarily by IFN-gamma producing elements: correlation between the number of IFN-gamma+ and CD4+ lymphocytes in patients 136
Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AIDS vaccine AT20-KLH 134
Multicenter Evaluation of the Anyplex™ Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-resistant Isolates in Pulmonary and Extrapulmonary Specimens 134
Lack of polarized type 1 or type 2 cytokine profile in asymptomatic HIV-1-infected patients during a two-year bimonthly follow-up. 133
CD8(+)CD28(-) T lymphocytes from HIV-1-infected patients secrete factors that induce endothelial cell proliferation and acquisition of Kaposi's sarcoma cell features. 133
Opposite effects of HIV-1 p17 variants on PTEN activation and cell growth in B cells 133
HIV-1 matrix protein p17: A candidate antigen for therapeutic vaccines against AIDS. 133
Reduced production of both Th1 and Tc1 lymphocyte subsets in atopic dermatitis (AD). 132
Contribution of CD4+, CD8+CD28+, and CD8+CD28- T cells to CD3 lymphocyte homeostasis during the natural course of HIV-1 infection. 132
Expression of Toll-like receptors on peripheral blood cells after allogeneic stem cell transplantation: ongoing results of a prospective study. 131
Expansion of rare CD8+ CD28- CD11b- T cells with impaired effector function in HIV-1-infected patients. 130
Generation of CD28- cells from long-term-stimulated CD8+CD28+ T cells: a possible mechanism accounting for the increased number of CD8+CD28- T cells in HIV-1-infected patients. 130
Lymphomagenic properties of a HIV p17 variant derived from a splenic marginal zone lymphoma occurred in a HIV-infected patient 130
Inducible nitric oxide synthase expression on human monocyte-derived cells in granulomatous reactions. 129
Long-lasting CD3+ T-cell deficiency after cord blood stem cell transplantation in a human herpesvirus 6-infected child. 128
Expression of inducible nitric oxide synthase in human granulomas and histiocytic reactions 126
HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype 126
Acute epididymo-orchitis due to Salmonella Typhi in a young man from Bangladesh 126
HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1. 125
Flow cytometric analysis of activation markers on stimulated t cells and their correlation with cell proliferation. 124
HIV-1 matrix protein p17 enhances the proliferative activity of natural killer cells and increases their ability to secrete proinflammatory cytokines 124
Humanization of an Antibody Recognizing a Breast Cancer Specific Epitope by CDR-grafting 123
Expression of inducible Nitric Oxide Synthase (iNOS) in monocytic cells from children with infections by intracellular pathogens 123
Circulation of human metapneumovirus-associated lower respiratory tract infections in inpatients children 122
Replication-deficient mutant Herpes Simplex Virus-1 targets professional antigen presenting cells and induces efficient CD4+ T helper responses. 121
TOLL-LIKE RECEPTORS ON PERIPHERAL BLOOD CELLS AND ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION: RESULTS OF A PROSPECTIVE STUDY 121
Expression of Toll-like receptors and Bteherpesvirus reactivation in the early period after allogeneic stem cell transplantation 120
Detection of a porcine-like rotavirus in a child with enteritis in Italy. 119
T cells from individuals in advanced stages of HIV-1 infection do not proliferate but express activation agents in response to HIV-1 specific antigens. 118
Co-infection of chlamydia pneumoniae and mycoplasma pneumoniae with SARS-CoV-2 is associated with more severe features 115
Differential production of IFN-g, analyzed at the single-cell level, by specific subset of human NK and T cells from healthy and HIV+ subjects 115
Functions of the HIV-1 matrix protein p17 114
A side-by-side comparison of the performance and time-and-motion data of VITEK MS 113
IFN-gamma Restores HIV and Non- HIV Specific Cell Mediated Immune Response In Vitro and Its Activity is Neutralized by Antibodies from Patients with AIDS. 111
First detection of SARS-CoV-2 spike protein N501 mutation in Italy in August, 2020 110
Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virological and clinical features 109
Emergence of Exhausted B Cells in Asymptomatic HIV-1-Infected Patients Naïve for HAART is Related to Reduced Immune Surveillance 108
HIV-1 matrix protein p17 prevents loss of CD28 expression during IL-2-induced maturation of naïve CD8+ T cells 108
POSSIBLE CORRELATION BETWEEN DIFFERENT TOLL-LIKE RECEPTORS, MONOCYTES, LYMPHOCYTE SUBSETS, TYPE OF INFECTIONS AND OUTCOME AFTER ALLOGENEIC STEM CELL TRANSPLANTATION 107
In-depth analysis of compartmentalization of HIV-1 matrix protein p17 in PBMC and plasma 107
Nutritional strategies to improve VRE control 107
HIV-1 matrix protein p17 prevents loss of CD28 expression durino IL-2-induced maturation of naive CD8 T cells. 106
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 105
PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF TUMOR-DERIVED MICROVASCULAR ENDOTHELIAL CELLS. 104
Circulation of human metapneumovirus-associated lower respiratory tract infections in inpatients children 103
Circulation of human metapneumovirus-associated lower respiratory tract infections in inpatients children. 103
Chronic Hepatitis C Cascade of Care in Prisoners—Is There Still Some Work to Do? Analysis of Two Large Penitentiaries in Northern Italy 102
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 101
Segregation of type 1 cytokine production in human peripheral blood lymphocytes: phenotypic differences between IFN-gamma and IL-2-producing cells in the CD8+ T cell subset. 101
Cytomegalovirus Infects Human Heart Microvascular Endothelial Cells Inducing the Production of Pro-Inflammatory Cytokines and Chemokines. 101
Evidence for Distinct Contribution of Heavy and Light Chains to Restriction of Antibody Recognition of the HIV-1 Principal Neutralization Determinant 100
TOLL-LIKE RECEPTOR EXPRESSION AND INFECTIOUS COMPLICATIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION. 100
Human Immunodeficiency Type 1 Matrix Protein p17 Increases the Ability of T cells to Secrete Proinflammatory Cytokines. 99
HIV-1 Matrix protein P!/ induces human plasmacytoid dendritic cells to acquire a migratory immature phenotype 99
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium 97
Totale 14.249
Categoria #
all - tutte 68.126
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.126


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021396 0 0 0 0 0 0 0 0 0 141 211 44
2021/20221.083 76 193 7 57 20 52 67 57 35 187 88 244
2022/2023883 133 12 9 94 87 239 4 82 142 5 30 46
2023/2024831 56 19 65 63 45 118 29 40 190 17 39 150
2024/20251.858 23 18 11 249 184 144 198 76 235 76 403 241
2025/20263.961 415 498 382 526 445 334 798 150 212 201 0 0
Totale 15.512